# Epic: Event Governance Framework for FDA Compliance

**Epic Type**: Architectural Enabler
**Priority**: Highest
**Technical Lead**: Melvin Jones

---

## Executive Summary

**Patient Safety Risk**: Dropped events in BioPro's blood product management system pose direct patient safety hazards. When critical events such as quarantine notifications, test result exceptions, or product unsuitability events are lost, unsuitable blood products could be released to patients, potentially causing serious injury or death.

**FDA Compliance Blocker**: FDA 510(k) submission requires demonstrated systematic handling of event processing failures with complete audit trails. Current state lacks systematic dead letter queue processing and failure tracking, creating a submission blocker that must be resolved before regulatory approval.

This architectural enabler establishes enterprise event governance framework to ensure no critical events are lost, all failures are tracked and auditable, and BioPro meets FDA requirements for risk mitigation procedures in event-driven blood product management.

---

## Business Context

### Patient Safety & Regulatory Compliance (Critical)

**Patient Safety Impact**
BioPro manages critical blood product safety events including:
- **Quarantine Events**: Products flagged as unsuitable for transfusion
- **Test Result Exceptions**: ABO/Rh incompatibilities, infectious disease markers
- **Product Unsuitability Events**: Manufacturing defects, contamination
- **Recall Notifications**: Batch recalls requiring immediate action

When these events are dropped due to processing failures, the system loses visibility into product safety status. This creates direct patient safety risk where unsuitable products could be released for transfusion, potentially causing:
- Hemolytic transfusion reactions (life-threatening)
- Disease transmission (HIV, Hepatitis, etc.)
- Allergic reactions or other adverse events
- Regulatory violations and patient harm

**FDA Regulatory Requirement**
FDA 510(k) submission requires:
- Documented risk mitigation procedures for all system failures
- Complete audit trail of event processing failures
- Demonstrated systematic handling of critical safety events
- Evidence that no safety-critical events can be silently dropped

Current ad-hoc error handling cannot demonstrate these requirements, creating submission blocker.

### Operational Driver
Production escalations from schema inconsistencies and event processing failures create support burden and impact system reliability. Support teams lack systematic tooling for investigating and resolving event processing issues.

### Strategic Driver
Establish reusable event governance platform that enables:
- Systematic dead letter queue processing preventing lost events
- Complete audit trail for all event processing failures
- Automated schema validation preventing malformed safety events
- Foundation for future interface development with built-in safety controls

---

## Solution Overview

### Core Capabilities

#### Systematic Failure Handling & Dead Letter Queue Processing
Establish comprehensive dead letter queue processing across all BioPro modules ensuring no critical safety events can be silently dropped. All event processing failures are automatically captured, logged, and routed to dead letter queues for systematic investigation and remediation. Support teams receive immediate notification of failures with full event payload and failure context.

**Business Value:**
- **Patient Safety**: Zero tolerance for dropped quarantine or test result events
- **FDA Compliance**: Complete audit trail of all event processing failures
- **Risk Mitigation**: Documented procedures for handling critical event failures
- **Operational Visibility**: Real-time alerting on safety-critical event failures
- **Regulatory Evidence**: Automated tracking and reporting for FDA submission

#### Centralized Schema Management
Establish single source of truth for all event schemas across BioPro ecosystem. Enable automatic validation at both producer and consumer level, preventing malformed messages from entering the system. Support schema evolution with backward compatibility guarantees, allowing modules to upgrade independently.

**Business Value:**
- Eliminate schema-related production incidents
- Accelerate development with pre-validated schemas
- Enable independent module deployment
- Provide regulatory audit trail for all schema changes

#### Automated Schema Evolution
Implement continuous integration pipeline that automatically detects schema changes in code, validates compatibility, and updates central registry. Eliminate manual schema management overhead while ensuring breaking changes are caught before deployment.

**Business Value:**
- Reduce development cycle time
- Prevent production schema conflicts
- Enable self-service schema publication
- Provide immediate feedback on compatibility issues

#### Living Event Documentation
Generate and maintain real-time documentation of all events, schemas, and service relationships. Provide developers and operations teams with self-service access to current event catalog, sample payloads, and integration patterns.

**Business Value:**
- Reduce onboarding time for new developers
- Eliminate outdated documentation issues
- Enable self-service integration
- Provide visibility into event-driven architecture


#### Enterprise Monitoring & Alerting
Implement comprehensive monitoring of event processing health with business-focused dashboards and proactive alerting. Enable visibility into system reliability and processing metrics required for FDA compliance reporting.

**Business Value:**
- Proactive issue detection before business impact
- Real-time compliance metrics
- Reduced system downtime
- Data-driven operational decisions

---

## High-Level Architecture

The solution establishes three foundational layers:

**Schema Governance Layer**
Central registry managing all event schemas with automated validation, versioning, and compatibility checking. Integrates with development workflow to validate changes before deployment.

**Event Documentation Layer**
Self-updating catalog providing real-time visibility into event architecture, schemas, and service relationships. Generates sample payloads and integration guides automatically from schema definitions.

**Processing Reliability Layer**
Common framework for event processing with systematic failure handling, retry policies, and comprehensive monitoring. Provides consistent patterns across all BioPro modules.

---

## Implementation Scope

### Schema Registry Foundation
- Deploy central schema registry infrastructure
- Establish schema validation pipeline
- Configure compatibility modes and governance policies
- Enable automated schema registration from CI/CD

### Event Catalog Platform
- Deploy event documentation platform
- Configure automatic schema synchronization
- Establish domain organization (Orders, Collections, Manufacturing, Distribution)
- Enable self-service event discovery

### Common Processing Framework
- Develop reusable dead letter queue library
- Implement retry policies and circuit breaker patterns
- Create monitoring instrumentation framework
- Establish failure investigation procedures

### BioPro Module Integration
Enable event governance across BioPro ecosystem through phased integration:

**Orders Module Integration**
- Migrate Orders service to schema-validated events
- Implement systematic DLQ processing
- Generate automated event documentation
- Establish baseline monitoring and metrics

**Collections Module Integration**
- Enable schema validation for blood collection events
- Implement failure handling framework
- Document collection event flows
- Establish cross-service schema validation

**Manufacturing Module Integration**
- Integrate manufacturing service suite (Apheresis, Whole Blood, Pooling)
- Enable schema governance for product events
- Implement systematic failure processing
- Document manufacturing event architecture

**Distribution Module Integration**
- Enable schema validation for distribution events
- Implement DLQ processing for outbound interfaces
- Document distribution event flows
- Validate external partner integrations

### CI/CD Automation
- Implement automated schema extraction from code
- Configure compatibility validation in pull request workflow
- Enable automatic schema registration on merge
- Establish automated documentation updates

### Compliance Reporting
- Implement FDA-required compliance dashboards
- Enable automated audit trail generation
- Establish real-time processing health metrics
- Create compliance evidence reporting

---

## Acceptance Criteria

### Patient Safety & FDA Compliance (Must Have)

**AC1: Zero Lost Safety-Critical Events**
- GIVEN a critical safety event (quarantine, test result exception, product unsuitability, recall)
- WHEN event processing fails for any reason
- THEN event is automatically captured in dead letter queue
- AND support team receives immediate notification
- AND complete event payload is preserved for recovery
- AND no safety-critical event can be silently dropped

**AC2: Complete Audit Trail**
- GIVEN any event processing failure across all BioPro modules
- WHEN failure occurs
- THEN complete audit record is created containing:
  - Event payload and schema
  - Failure timestamp and cause
  - Retry attempt history
  - Resolution status and timestamp
- AND audit trail is queryable for FDA compliance reporting
- AND audit records are retained per regulatory requirements

**AC3: Systematic Failure Recovery**
- GIVEN an event in dead letter queue
- WHEN support team investigates failure
- THEN failure cause is clearly documented
- AND event can be reprocessed or manually handled
- AND resolution is tracked in audit trail
- AND similar failures are preventable via alerts

**AC4: FDA Submission Evidence**
- GIVEN FDA 510(k) submission requirements
- WHEN compliance evidence is needed
- THEN system can demonstrate:
  - All event types have systematic failure handling
  - Complete audit trail exists for all failures
  - Risk mitigation procedures are documented
  - No critical events can be lost
- AND compliance reports can be generated on demand

### Schema Governance & Validation (Must Have)

**AC5: Schema Validation in CI/CD**
- GIVEN a developer makes schema changes to event classes
- WHEN pull request is created
- THEN schema is automatically extracted from code
- AND compatibility is validated against schema registry
- AND breaking changes fail the build
- AND PR includes schema change summary
- AND backward-compatible changes are allowed

**AC6: Automatic Schema Registration**
- GIVEN a backward-compatible schema change
- WHEN code is merged to main branch
- THEN new schema version is automatically registered
- AND schema ID is returned for producer/consumer use
- AND event documentation is updated automatically
- AND schema change is tracked in audit trail

**AC7: Schema-Based Message Validation**
- GIVEN a producer publishes an event
- WHEN message is serialized
- THEN schema validation occurs before publishing
- AND schema ID is embedded in message
- AND invalid messages cannot be published
- GIVEN a consumer receives an event
- WHEN message is deserialized
- THEN schema is retrieved from registry by ID
- AND message is validated against schema
- AND schema mismatches are detected and handled

### Event Documentation & Discovery (Should Have)

**AC8: Real-Time Event Catalog**
- GIVEN schema changes are registered
- WHEN schema registration completes
- THEN event catalog is updated automatically within 5 minutes
- AND all schema fields are documented
- AND sample event payloads are generated
- AND producer/consumer relationships are visible
- AND developers can discover events self-service

**AC9: Service Dependency Visualization**
- GIVEN events flowing between BioPro services
- WHEN viewing event catalog
- THEN service dependency graph shows:
  - Which services produce which events
  - Which services consume which events
  - Event flow across domain boundaries
- AND dependencies are updated automatically

### Enterprise Monitoring & Alerting (Should Have)

**AC10: DLQ Health Monitoring**
- GIVEN dead letter queues across all modules
- WHEN monitoring dashboard is viewed
- THEN real-time metrics show:
  - DLQ message count per topic
  - Processing success/failure rates
  - Average processing time
  - Failure trends over time
- AND thresholds trigger automatic alerts

**AC11: Safety-Critical Event Alerting**
- GIVEN a safety-critical event fails processing
- WHEN failure is detected
- THEN immediate alert is sent to support team
- AND alert includes event type and failure context
- AND escalation occurs if not acknowledged
- AND alert history is tracked for compliance

### Platform Adoption (Must Have)

**AC12: Consistent Failure Handling Framework**
- GIVEN all BioPro modules (Orders, Collections, Manufacturing, Distribution)
- WHEN modules are integrated with event governance
- THEN all modules use common DLQ processing library
- AND all modules follow consistent retry policies
- AND all modules report to centralized monitoring
- AND failure handling is standardized enterprise-wide

**AC13: Schema Governance Enforcement**
- GIVEN any BioPro module producing or consuming events
- WHEN module is deployed to production
- THEN all events are registered in schema registry
- AND all events use schema-validated serialization
- AND backward compatibility is enforced
- AND no ad-hoc schema changes are permitted

---

## Business Value

### Immediate Value

**Patient Safety (Critical)**: Zero tolerance for dropped safety-critical events ensures unsuitable blood products cannot be released due to lost quarantine or test result notifications

**FDA Compliance (Critical)**: Unblocks regulatory submission with demonstrated systematic event failure handling and complete audit trail required for 510(k) approval

**Risk Mitigation**: Documented procedures for handling all event processing failures provide regulatory evidence and reduce patient safety risk

**Operational Reliability**: Systematic failure handling reduces production incidents and support burden

**Development Velocity**: Automated schema validation and documentation eliminates manual coordination overhead

**Visibility**: Enterprise-wide monitoring enables proactive issue detection and data-driven decisions

### Long-term Value
**Reusable Platform**: Foundation for all future BioPro event-driven integrations

**Quality Assurance**: Schema validation prevents entire class of production defects

**Operational Efficiency**: Consistent patterns and tooling reduce maintenance complexity

**Enterprise Architecture**: Alignment with event-driven architecture standards and best practices

---

## Risk Mitigation

### Risks Without This Enabler

**Patient Safety Risk (Critical)**
- Quarantine events could be silently dropped, allowing unsuitable products to be released
- Test result exceptions could be lost, resulting in ABO-incompatible transfusions
- Product unsuitability events could fail to process, bypassing safety controls
- No systematic mechanism to detect or recover from critical event failures

**Regulatory Risk (Critical)**
- Inability to demonstrate FDA-required event processing failure handling
- Incomplete audit trail for risk mitigation procedures creating submission blocker
- Cannot provide regulatory evidence that safety-critical events are systematically handled
- Potential regulatory submission delay or rejection

**Operational Risk (High)**
- Continued production incidents from schema inconsistencies
- Manual investigation burden on support teams
- Limited visibility into event processing health
- Uncontrolled schema evolution causing integration failures

**Technical Risk (Medium)**
- Inconsistent error handling across modules
- Ad-hoc schema management creating maintenance burden
- Lack of reusable patterns increasing development complexity

### Mitigation Strategy
Phased implementation approach enables incremental value delivery while minimizing production risk. Each module integration builds on proven patterns from previous phases. Core infrastructure components provide immediate value before full module integration.

---

## Dependencies

### Infrastructure Requirements
- Schema registry deployment and configuration
- Event catalog platform hosting
- Monitoring platform integration
- CI/CD pipeline configuration

### Team Coordination
- Module teams for integration validation
- Infrastructure teams for platform deployment
- Support teams for operational procedure establishment
- Compliance teams for documentation review

---

## Benefit Hypothesis

**We believe that** implementing systematic event governance with dead letter queue processing and automated schema validation

**Will result in** zero lost safety-critical events, complete FDA-compliant audit trails, and elimination of schema-related production incidents

**Which will be confirmed when we see:**
- Zero quarantine or test result events lost due to processing failures (measured via DLQ audit trail)
- 100% of event processing failures captured and auditable for FDA compliance reporting
- Reduction in schema-related production incidents from current baseline to zero within first quarter post-implementation
- FDA submission evidence package completed with documented risk mitigation procedures
- Support team investigation time for event failures reduced by 75% via systematic DLQ tooling
- Schema change validation in CI/CD preventing breaking changes before production deployment

---

## Recommendation

Approve as architectural enabler with highest priority due to FDA compliance requirement and significant operational value. Core infrastructure provides foundation for all BioPro event-driven architecture while addressing critical regulatory gap.

**Confidence Level**: High - Proof of concept validates technical approach and demonstrates feasibility of all core components.

---

**Created By**: Melvin Jones
**Labels**: architectural-enabler, fda-compliance, event-governance, high-priority
